At Anlong Bio, patients are our priority. Since launching, our goal has been to deliver transformative gene therapy medicines to patients faster and at low cost, in China and globally.
We aim to provide unmatched access to treatments for patients through our extensive resources, our experienced leadership and advisory teams, and our trusted network of partners.
Company Details
- Employees
- 44
- Founded
- -
- Address
- 10 Anxiang Street,shunyi,beijing, Beijing,china
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://anlongbio.com
- Keywords
- lentivirus, AAV, Gene Therapy, RNAi, Scalable Manufacturing, CRISPR, Gene Editing, Ocular Gene Therapy, wAMD, dAMD, He, HemB/A, mRNA, Global Expansion, Business Development, Clinical Development, China Go to Market.
- HQ
- Beijing
Anlong Bio Questions
Anlong Bio's website is http://anlongbio.com
Anlong Bio's LinkedIn profile is https://cn.linkedin.com/company/anlongbio
Anlong Bio has
44 employees.
View email and phone details for 44
employees at Anlong Bio.
Anlong Bio's industry is
Biotechnology Research
Anlong Bio's top competitors are
Bonito Biosciences,
Triastek, Inc.,
Vietnam National Coffee Corporation - (Vinacafe),
Nutrigeneai Biotech Limited,
Eurotec Nutrition Group,
Unicmicro Co., Ltd.,
Tianda Pharmaceuticals Limited,
Factoryhood.com,
Staidson (Beijing) Biopharmaceuticals Co., Ltd,
Formic Ventures.
Anlong Bio's categories are Biotechnology Research
Anlong Bio's founding year is 2019
